The fertility industry in China is using artificial intelligence technology to solve the problem of declining birth rates in the country. BGI Genomics, which stands as a top Chinese biotechnology firm, creates AI-based chromosome screening solutions that enable faster and more precise and efficient in vitro fertilisation (IVF) procedures.
The technology scans embryos before implantation, helping doctors select those most likely to develop into healthy pregnancies. The process detects chromosome imbalances that result from missing or extra chromosomes which lead to miscarriage and failed IVF cycles and genetic conditions.
How does AI improve IVF success rates?
Traditionally, preimplantation genetic testing requires skilled specialists and time-consuming analysis. AI automates much of this work, identifying subtle genetic patterns that may escape human analysts.
“By automating embryo analysis, clinics can make faster, more consistent decisions about implantation,” BGI Genomics says. This reduces the emotional and financial burden for patients who often undergo multiple IVF attempts.
China has reached its lowest birth rate in history because its family planning rules no longer restrict couples from having children. Couples in the present day choose to remain childless because they face financial difficulties and work demands and social transformations. The need for assisted reproductive technologies such as IVF has increased.
Fertility clinics can increase their patient capacity through AI integration, which also enhances treatment success rates. The combination of these benefits helps clinics establish better market presence while receiving increased financial support.
The use of AI in embryo selection raises ethical and privacy concerns. Genetic data requires strict protection measures because it contains extremely sensitive information which experts consider to be highly confidential. Chinese authorities are increasing their regulatory activities to verify that artificial intelligence systems comply with ethical requirements while ensuring patient protection.
